2008
DOI: 10.1097/pas.0b013e31816b8fce
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of CD10 and Procollagen 1 Expression in Atypical Fibroxanthoma and Dermatofibroma

Abstract: Atypical fibroxanthoma (AFX) (dermal pleomorphic sarcoma) remains a somewhat controversial entity. Some authors have averred that AFX is a fiction, suggesting that such lesions merely represent misclassified examples of spindled squamous cell carcinoma. In addition, the immunoperoxidase confirmation of AFX has been less than straightforward and has historically been approached as a diagnosis of exclusion because of the lack of sensitivity and specificity of available "positive" reagents. Procollagen 1 (PC1) an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
88
0
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 94 publications
(96 citation statements)
references
References 35 publications
6
88
0
2
Order By: Relevance
“…Moreover, lysozyme was also positive. CD10 is expressed on a variety of tumor cell types, including fibrohistiocytic tumors [30]. The present case was strongly positive by CD10 and was useful adjunct to supplement the diagnosis of JXG.…”
Section: Discussionmentioning
confidence: 86%
“…Moreover, lysozyme was also positive. CD10 is expressed on a variety of tumor cell types, including fibrohistiocytic tumors [30]. The present case was strongly positive by CD10 and was useful adjunct to supplement the diagnosis of JXG.…”
Section: Discussionmentioning
confidence: 86%
“…Similar reactivity has been noted in association with non-hematopoietic and lymphoid cutaneous neoplasms and inflammatory skin conditions. [6][7][8][9][10]42 One patient (patient 9) demonstrated only rare CD10( þ ) cells by immunohistochemistry despite having CD10( þ ) mycosis fungoides/Sezary syndrome cells in the peripheral blood. This patient had 5-15% abnormal CD10( þ )CD4( þ ) T cells detected in the blood in eight separate samples over 3 years.…”
Section: Resultsmentioning
confidence: 99%
“…1 CD10 expression has been described on a number of cells types and neoplasms that involve skin including the perifollicular fibrous sheath of the hair follicle, dermal fibroblasts, neutrophils, germinal center B cells, lymphomas of germinal center cell origin, melanoma, atypical fibroxanthoma and a variety of mesenchymal tumors. [2][3][4][5][6][7][8][9][10][11][12] Additionally, CD10 is expressed on a subset of CD4( þ ) T cells residing in the lymph node follicle germinal center termed follicular helper T cells. 13 These T cells are also known to express PD-1, CXCL-13, CD57, CXCR5, SAP, and ICOS with their differentiation controlled by Bcl-6.…”
mentioning
confidence: 99%
“…In contrast, several other recently developed markers, including procollagen-1 (PC-1), CD10, and CD99, appear perhaps more specific for AFX. 41,42 Still, at the present time the most effective means to differentiate AFX from MFH on histologic examination appears to be depth of invasion. It is important to note that MFH may involve both the superficial dermis and deeper tissues As the most appropriate management strategy hinges on an accurate diagnosis, it is paramount that a diagnosis of AFX is not made without visualization of deep margins on biopsy.…”
Section: Immunohistochemistrymentioning
confidence: 92%